Key result
Microcoil embolization successfully seals rotablation-induced type 2 coronary perforation during PCI with abciximab.
Why the study?
Coronary artery perforation during rotablation and stenting in patients treated with abciximab requires effective management strategies.
Case Report (n=1)
Coil embolization with Trufill pushable coils can successfully treat type 2 coronary artery perforation in patients receiving abciximab during percutaneous coronary intervention.
Answers are grounded in this paper and cite their sources.
May offer bailout for type 2 perforation during abciximab-treated PCI; hypothesis-generating and requires prospective validation.
We describe a case of type 2 coronary artery perforation in a 73-year-old man undergoing coronary artery rotablation and stenting with abciximab therapy. The coronary artery perforation was successfully treated by coil embolization with Trufill pushable coils made from platinum alloy and synthetic fibers to promote maximum thrombogenicity. Cathet. Cardiovasc. Intervent. 51:487–489, 2000.
No takes yet. Share an insight, caveat, or question.
Assali et al. (2000) conducted a case report in Type 2 coronary artery perforation (n=1). Microcoil embolization (Trufill pushable coils) was evaluated on Successful treatment of coronary artery perforation. Microcoil embolization using Trufill pushable coils successfully treated a type 2 coronary artery perforation in a 73-year-old man undergoing rotablation and stenting with abciximab therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: